SHOPLINE and XRC Ventures have marked a major milestone for early-stage consumer brands with the launch of the XRC Brand Builder Grant. With eight chosen startups, each receiving up to $50,000 in non-dilutive capital, this program brings much-needed resources and spotlight to founders building the next generation of consumer packaged goods (CPG) brands in today’s challenging marketplace.
Unlike traditional venture capital, which increasingly favors startups already showing $1–3 million in annual revenue or a retail purchase order, this grant targets the “missing middle” of early-stage innovators, those with momentum, vision, and impact, who just need vital support to scale. Factors like rising customer acquisition costs and tough funding climate have made it difficult for newer brands to stand out. Through this grant, SHOPLINE and XRC Ventures are providing founders a rare competitive edge: capital, robust tech infrastructure, and coaching, all without giving up equity.
Grantee Startups: Innovators Across Beauty, Health,…
Food & Apparel The grant program’s reach was vast, drawing over 120 applications spanning beauty, wellness, food, beverage, and apparel.
The eight selected startups are already impacting their industries: AnaOno: Pioneers in post-surgical intimates for breast cancer patients, survivors, and previvors, AnaOno partners with Victoria’s Secret, Soma, and ThirdLove to redefine comfort and beauty for over 100,000 individuals.
Caire Beauty: A biotech-forward line making pro-aging skincare relevant for women 40+ with delivery systems targeting deep collagen and hydration for firmer, clearer skin.
Fila Manila: Dedicated to developing Filipino American pantry staples, this brand is pioneering growth in the under-represented $2.2 billion Filipino CPG food segment. FocusFuel: Changing the future of energy with crash-free functional gummies that deliver reliable focus anytime, anywhere, with two million units sold…
Discussion
0 Comments
No comments yet
Start the conversation
Share your take on this story and help shape the discussion.
Sign in to join the discussion.